News Archive of BioSpace - Breaking News

ArticleAdded
ISCTM Pushes for Innovation in the Development of Novel Therapies for CNS Disorders 02-03-12
Statement from Susan G. Komen for the Cure Board of Directors and Founder and CEO 02-03-12
GENFIT Corp. Release: The GFT505-210-6 Study Reaches All Its Efficacy Objectives With No Adverse Effects 02-03-12
Positive Data Presented on Athersys, Inc.' MultiStem to Treat Stroke 02-03-12
Watson Pharmaceuticals, Inc. Provides Update on Generic Lidoderm(R) Application 02-03-12
Talon Therapeutics, Inc.' Product Candidate Marqibo(R) to be Assessed by Oncologic Drug Advisory Committee (ODAC) on March 21, 2012 With a PDUFA Date of May 13, 2012 02-03-12
MannKind Corporation Announces Pricing of Public Offering of Units Consisting of Common Stock and Warrants to Purchase Common Stock 02-03-12
CORRECTING and REPLACING Cook Medical Launches Zenith?? Low Profile Endovascular Graft in Canada 02-03-12
Bristol-Myers Squibb Company Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Inhibetex Therapeutics Inc. 02-03-12
MannKind Corporation Receives Commitment from the Mann Group to Acquire 31,250,000 Shares of Common Stock 02-03-12
Synthetic Genetics and Integrated DNA Technologies Sign Agreement to Manufacture, Market, and Commercialize Small Synthetic Gene Products Using SGI Technology 02-03-12
OptiNose AS Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology 02-03-12
Exelixis, Inc. Release: Cabozantinib Shows Encouraging Activity in Heavily Pretreated Patients with Advanced Renal Cell Carcinoma 02-03-12
CSL Behring Release: International Phase I Trial Results of Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) Show All Pharmacokinetic Parameters Significantly Improved in Patients With Severe Hemophilia B 02-03-12
OncoGenex Pharmaceuticals Inc. Release: Clinical Data on OGX-427 Presented at the ASCO 2012 Provide Ongoing Evidence of Hsp27 as a Potential Therapeutic Target in Advanced Prostate Cancer 02-02-12
Diamyd Medical AB's Phase III Study Published in The New England Journal of Medicine 02-02-12
Ipsen??'s Fourth Quarter and Full year 2011 Sales and Other Significant Developments 02-02-12
Mylan Inc. Receives Tentative FDA Approval for Generic Version of Lipitor(R) 02-02-12
ThromboGenics Ltd. Announces That the FDA Intends to Grant Ocriplasmin Priority Review 02-02-12
Dynavax Technologies Corporation Reports on Heplisav(TM) Pre-BLA Meeting With FDA 02-02-12
Bedford Laboratories Issues a Voluntary Nationwide Patient Level Recall of Acetylcysteine Solution, USP, Lot 1877093 02-02-12
Acsis, Inc. Releases the latest ProducTrak??? Solutions 02-02-12
Biotechnology Industry Organization (BIO) Testifies on Importance of Prompt Enactment of PDUFA V Recommendations 02-02-12
Verastem, Inc. Release: Underwriters Exercise Over-Allotment Option for Verastem Initial Public Offering 02-02-12
Pozen, Inc. Release: Preventive Aspirin Use Less Than Optimal in Stroke Survivors Despite Clinical Guidelines 02-02-12
AHF Calls for Congressional Investigation and Shake Up at FDA 02-02-12
Hybrid Fuels, Inc. Announces FDA Approved Lab Selection for Azul Instant??? - "Be Ready in an Instant" 02-02-12
Affinium Pharmaceuticals Announces First Patient Dosed with Oral AFN-1252 in a Phase 2 Clinical Trial for Acute Bacterial Skin & Skin Structure Infections 02-01-12
Affinium Pharmaceuticals, Ltd., Announces First Patient Dosed with Oral AFN-1252 in a Phase 2 Clinical Trial for Acute Bacterial Skin & Skin Structure Infections 02-01-12
Halozyme Therapeutics, Inc. Release: HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial 02-01-12
Ablynx Receives Another EUR $5 Million Milestone as Boehringer Ingelheim Corporation Selects Nanobody Candidate for Pre-Clinical Development 02-01-12
AB Science Reports Positive Clinical Study Data: Masitinib Significantly Extends Overall Survival as Compared to Pfizer Inc.'s Sutent??in Gleevec??-resistant GIST 02-01-12
American Heart Association Release: Experimental Drug Reduces "Second Stroke" After Aneurysm Rupture 02-01-12
ErgoD2 Achieves Important Safety Milestone for Entia Biosciences 02-01-12
American Heart Association Release: Infections in Childhood Linked to High Risk of Ischemic Stroke 02-01-12
Infectious Disease Research Institute (IDRI) Supports the First Phase 1 Human Hookworm Vaccine Clinical Trial 02-01-12
Starpharma Holdings Ltd's Dendrimers Improve Efficacy of Docetaxel in Animals 02-01-12
European Medicines Evaluation Agency Approves Orphan Medicinal Product Application of Acute Myeloid Leukemia Vaccine 02-01-12
YOLO Medical Inc. Announces YOLO Curve Receives Health Canada Approval 02-01-12
Dendreon Corporation Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology 2012 Genitourinary Cancers Symposium 02-01-12
BioMed Realty and Omeros Corporation Sign New 64,500 Square Foot Lease in Seattle 02-01-12
Foundation Medicine ReceivesCenters for Medicare & Medicaid Services Certification for its Genomic Sequencing Laboratory 02-01-12
cGMP CMO Announces EU Compliant Aseptic Fill-Finish and Facility Enhancements for Biopharmaceutical Drug Products 02-01-12
Almac Group Announce Launch of Next Generation Sequencing (NGS) Data Analysis Services 02-01-12
Illumina, Inc. Comments on Roche??'s Director Nominees and Proposals 02-01-12
ImmunoCellular Therapeutics, Ltd Receives Notice of Allowance of Cancer Stem Cell Targeting Patent 02-01-12
Cook Medical Launches Zenith?? Low Profile Endovascular Graft in Canada 02-01-12
D&R Acquires LATHIAN to Create Leading Multichannel Marketing Agency 02-01-12
MEDIAN Technologies has Signed a Landmark Contract with the Top Pharmaceutical Company Sanofi Pasteur for Medical Image Interpretation and Management in a New Phase II Study on Small Cells Lung Cancer 02-01-12
Pfizer Inc., Eli Lilly and Company Profits Fall as Drugs Lose Patents 02-01-12
AcelRx Pharmaceuticals Announces its ARX-01 Phase 3 Program Expected to Start Late Q1 or Early Q2 2012 01-31-12
Mesoblast Limited Receives FDA Clearance for Phase 2 Clinical Trial of Proprietary Stem Cell Therapy in Type 2 Diabetes 01-31-12
McKesson Corporation to Acquire Independent Banner and Franchise Businesses of 01-31-12
New Clinical Data for Symphony Presented in Late Breaking Clinical Trials Session at the Annual Meeting 01-31-12
NanoViricides, Inc. Submits Pre-IND Briefing Document for its Anti-Influenza Drug, FluCide???, to the US FDA 01-31-12
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) and Initiate Phase II RECOVER-ERC Heart Failure Trial 01-31-12
Alkermes plc Initiates Open-Label Pilot Study of VIVITROL?? to Evaluate Impact on Re-Arrest and Re-Incarceration in Offenders with History of Opioid Dependence 01-31-12
Lannett Company, Inc. Receives FDA Approval for ANDA Supplement for Phentermine HCL Capsules, 15 mg 01-31-12
NPS Pharmaceuticals, Inc. Announces FDA Acceptance of New Drug Application for GATTEX?? (teduglutide) for the Treatment of Adult Short Bowel Syndrome (SBS) 01-31-12
Daiichi Sankyo, Inc. Logs Loss 01-31-12
Curis, Inc. Announces FDA Approval of Erivedge(TM) (vismodegib) Capsule as First Treatment for Advanced Basal Cell Carcinoma 01-30-12
Vical Incorporated Presents Case Study on Successful Design of Allovectin(R) Phase 3 Melanoma Trial 01-30-12
ZIOPHARM Oncology, Inc. Announces Recommendation by Independent Data Monitoring Committee to Continue Phase 3 Study of Palifosfamide in Metastatic Soft Tissue Sarcoma 01-30-12
Cell Therapeutics, Inc. Withdraws New Drug Application for Pixuvri(TM) and Plans to Resubmit in 2012 01-30-12
FDA Approves Pfizer Inc.'s INLYTA?? (axitinib) for Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC) 01-30-12
Advanced Cell Technology Announces Aberdeen University Royal Infirmary in Scotland as Additional Site for Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration 01-30-12
ISTA Pharmaceuticals, Inc. Completes Patient Enrollment in Phase 2 Clinical Study of BEPOSONE(TM) (Bepotastine Besilate - Steroid Combination Nasal Spray) for the Treatment of Symptoms Associated With Seasonal Allergic Rhinitis 01-30-12
Allos Therapeutics, Inc. Announces Interim Results from Phase 1 Combination Study of FOLOTYN?? and Bexarotene Demonstrate Activity in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma 01-30-12
AMAG Pharmaceuticals, Inc. Announces Completion of Enrollment in its Phase III Program Evaluating Feraheme for a Broader Iron Deficiency Anemia Indication 01-30-12
KineMed, Inc. Announces Research Collaboration with Pfizer Inc. for the Advancement of Novel Approaches in Metabolic Disease 01-30-12
Lannett Company, Inc. Receives FDA Approval for Hydrochlorothiazide Capsules, 12.5 mg 01-30-12
GlaxoSmithKline Seeking Acquisition in Turkey 01-30-12
GenVec Inc. Extends Research Collaboration with Global Pharmaceutical 01-27-12
Apricus Biosciences Expands Commercial Oncology Offerings Through Agreement With Pediatrix for U.S. Co-Promotion of GRANISOL(R) (Granisetron) Oral Solution and AQUORAL(TM) Spray and Purchase of Non-U.S. Rights to GRANISOL(R) 01-27-12
Ipsen Acknowledges Tanakan?? Delisting in France 01-27-12
Cornerstone Therapeutics Inc. Release: New Analysis Shows Lower Mortality Rates and Less Need for Redosing When Treating Neonatal Respiratory Distress Syndrome With CUROSURF(R) vs. Survanta(R) 01-27-12
Celgene Acquisition of Partner, Avila Therapeutics, Significant Advance for Novel Blood Cancer Therapy 01-27-12
Lpath, Inc. Temporarily Suspends Dosing of iSONEP in Clinical Trials Due to cGMP Compliance Issues at Contract Fill/Finish Source 01-27-12
Independent Data Published on BioLife Solutions, Inc. HypoThermosol?? and CryoStor?? 01-27-12
Infinity Pharmaceuticals Inc. Halts Phase II Cancer Drug Trial, Shares Fall -3.87(38.90%) @ 12:55PM EST 01-27-12
Cytokinetics, Inc. to Announce Fourth Quarter and Year End Results on February 2, 2012 01-27-12
Johnson & Weaver, LLP Announces Investigation in Connection with the Possible Acquisition of Illumina, Inc. by Roche 01-27-12
Advaxis, Inc. CEO Interviewed by OneMedPlace Regarding Preliminary Data 01-27-12
Incyte Corporation to Report Fourth Quarter/Year-End 2011 Financial Results on February 15 01-27-12
World-Renowned Cell-Therapy Researcher, Joins Texas Heart Institute at 01-27-12
Alkermes plc to Host Conference Call to Discuss Financial Results for Third Quarter of Fiscal 2012 01-27-12
Gilead Sciences, Inc. to Release Fourth Quarter and Year End 2011 Financial Results on Thursday, February 2, 2012 01-27-12
Roche Responds to Adoption of Shareholder Rights Plan by Illumina, Inc. Board of Directors 01-27-12
Spectrum Pharmaceuticals, Inc. Strengthens Commercial Operations 01-27-12
Seattle Genetics, Inc. Announces Data from ADCETRIS??? in Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma 01-27-12
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company Report Data from Phase I Trial of ADCETRIS??? in Front-line Mature T-Cell Lymphomas 01-27-12
Watson Pharmaceuticals, Inc. Reaches Settlement With Mallinckrodt Inc. Over Exalgo(R) 01-27-12
Pfizer Inc. Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ Chronic Myeloid Leukemia 01-27-12
Biogen, Inc., and Elan Corporation PLC Release: ASCEND Study to Evaluate the Effectiveness of TYSABRI?? (natalizumab) as a Treatment for Secondary-Progressive Multiple Sclerosis 01-26-12
Vanda Pharmaceuticals, Inc. Release: Initial Clinical Data Reveal Potential of Tasimelteon to Reset the Body Clock in Non-24-Hour Sleep-Wake Disorder 01-26-12
Green Cross Gains Market Approval With the World's 2nd Orphan Drug for Hunter Syndrome in South Korea 01-26-12
Elite Pharmaceuticals, Inc. Announces FDA Approval of Supplemental Application for Hydromorphone 01-26-12
IntelliCell BioSciences Filed Patent Application for its Proprietary Method of Manufacturing Stromal Vascular Fraction Cells 01-26-12
Celator Pharmaceuticals, Inc. Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid Leukemia 01-26-12
Mayo Clinic Release: Combo Treatment Helps Heal Overused, Aching Joints 01-26-12
Advaxis, Inc. Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer 01-26-12
REPEAT/Advaxis, Inc. Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer 01-26-12
Tysabri, Biogen, Inc., and Elan Corporation PLC Release: ASCEND Study to Evaluate the Effectiveness of TYSABRI?? (natalizumab) as a Treatment for Secondary-Progressive Multiple Sclerosis 01-26-12
Boehringer Ingelheim Corporation Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib* 01-26-12
Unity Management Group Subsidiary Announces First Contracts of 2012 With Purdue Pharma L.P. and Novartis AG 01-26-12
CEL-SCI to Raise $5.76 Million in Registered Direct Offering 01-26-12
Chimerix, Inc. Announces Presentation of Final Data from CMX001 Phase 2 Trial in Prophylaxis of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients 01-25-12
Amorcyte Inc., a NeoStem, Inc. Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction 01-25-12
OctoPlus Announces the Proposal to Appoint to the Supervisory Board 01-25-12
Depomed, Inc. Announces Initiation of Phase 2 Clinical Study in Parkinson's Disease 01-25-12
Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Starts Cohort 2 of Its Phase 1b START-FAP Clinical Trial of CEQ508 01-25-12
Gilead Sciences, Inc. Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir for the Treatment of HIV 01-25-12
Advanced Cell Technology Announces that Additional Patient with Stargardt??'s Disease Has Undergone Embryonic Stem Cell Transplantation at University of California, Los Angeles (UCLA)??'s Jules Stein Eye Institute 01-25-12
AnaSpec, Inc. Offers Symmetric & Asymmetric Dimethylated Arginine in Histone Peptides Collection 01-24-12
Novartis AG Cautious on Outlook as Profit Drops 46% 01-25-12
Macoven Pharmaceuticals, LLC Named in Suit for Patent Violation and Lanham Act Violation 01-25-12
Almirall and Galapagos NV Enter Research Alliance for Up to EUR $7.5 Million 01-25-12
UCB, Inc. Announces FDA Approval for Keppra?? in Infants and Children from One Month of Age with Partial Onset Seizures 01-25-12
Merck & Co., Inc.'s Cholesterol Drug Vytorin to Get New Label 01-25-12
Aptalis Pharmaceutical Technologies Announces FDA Approval of NDA for Oral Powder Formulation of Viread(R), Co-Developed with Gilead Sciences, Inc. 01-24-12
Boston Therapeutics, Inc. Announces Clinical Study Safety Results With SUGARDOWN(R) at University of Sydney 01-24-12
Advanced Cell Technology Publishes First Report of Embryonic Stem Cell (ESC)-Derived Cells Transplanted Into Patients 01-24-12
Roche Release: HPV Testing for Cervical Cancer Risk Patients Set to Increase 01-24-12
Van Andel Institute Study Provides New Details of Fundamental Cellular Process 01-24-12
ImmunoCellular Therapeutics, Ltd: Targeting Cancer Stem Cells 01-24-12
Appistry, Inc. Establishes Genomic Research Collaboration with University of Missouri 01-24-12
Santhera Pharmaceuticals AG and Ipsen Renegotiate Fipamezole Licensing Agreement 01-24-12
BioLineRx Ltd. Signs Exclusive License Agreement for BL-8020, an Oral Treatment for Hepatitis C 01-24-12
IMS Health Acquires in India, Strengthening Global Services Capabilities 01-24-12
LAB21 Limited Acquires New Real Time PCR Technology 01-24-12
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) and Licensee ERCell Receive Russian Regulatory Approval for the RECOVER-ERC Trial 01-24-12
Adipose Stem Cell Heart Attack Trial Data Published in Journal of the American College of Cardiology; Cytori Therapeutics, Inc.'s APOLLO Trial Demonstrated Safety & Feasibility and Improvements in Cardiac Function 01-24-12
POET Gets New Partner in $250 Million Cellulosic Ethanol Plant in Iowa 01-24-12
immatics biotechnologies GmbH Presents Positive Phase II Results With its Therapeutic Cancer Vaccine IMA910 in Patients With Advanced Colorectal Cancer at the 2012 American Society of Clinical Oncology Gastrointestinal Cancers Symposium 01-24-12
Roche Settles Claims Over Genentech's Raptiva Psoriasis Drug, Lawyer Says 01-24-12
B.Braun Medical Becomes the First to Deliver FDA-Approved 2g Cefazolin 01-23-12
Enlivex Therapeutics Ltd. Completes Patient Enrollment in its Phase I/II Clinical Trial 01-23-12
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) Prepares to Launch Global Phase 2b Ophthalmic Study of NVC-422 01-23-12
Carolus Therapeutics Reports Publication of Preclinical Data for CT-2009 Supporting Development in Acute Lung Injury 01-23-12
Infinity Pharmaceuticals Inc. Reports New Data from Phase 1b Trial of Saridegib in Patients with Pancreatic Cancer at 01-23-12
Advanced Cell Technology Announces Europe??'s First Human Embryonic Stem Cell Transplant in Patient with Stargardt??'s Disease 01-23-12
Active Biotech AB's Prostate Cancer Project TASQ in Phase I Combination Therapy Trial 01-23-12
EpiCept Corporation Receives Finalized FDA Guidance for AmiKet??? Phase III CIPN Program and Regulatory Strategy 01-23-12
ImmunoCellular Therapeutics, Ltd Provides Update on Phase II Clinical Trial of ICT-107 for the Treatment of Glioblastoma 01-23-12
Trius Therapeutics Earns $5 Million Milestone Payment From Bayer HealthCare for Successful Completion of First Phase 3 Trial of Tedizolid 01-23-12
Exelixis, Inc. Reports Positive Preliminary Phase 2 Cabozantinib Data in Patients With Hepatocellular Carcinoma 01-23-12
Chikujee Therapeutics, Inc. and Avanti Therapeutics Achieve Key Pre-Clinical Milestone in Ovarian Cancer Program 01-20-12
Mylan Inc. Launches Innovative Version of Antiepileptic Drug Levetiracetam 01-20-12
Jiangsu Kanion Out-licenses 3 Molecules to NewGen Therapeutics 01-20-12
PolyMedix Inc. Defensin-Mimetic Antimicrobial Compounds Show Activity Against Oral Candida Fungus and Malaria 01-20-12
Avila Therapeutics Announces FDA Allowance of Partner Clovis Oncology??'s IND Application for CO-1686, an Oral EGFR Mutant-Selective Inhibitor, Triggers $4 Million Milestone Payment to 01-20-12
Galena Biopharma Initiates Patient Enrollment in NeuVax(TM) Phase 3 PRESENT Trial to Prevent Breast Cancer Recurrence 01-20-12
Cubist Pharmaceuticals, Inc. Reports 2011 Fourth Quarter and Full Year Financial Results 01-20-12
Rainbow Coral Corp. Release: Rainbow BioSciences, LLC Targets Booming Diabetes Research Market 01-20-12
Thermo Fisher Scientific Expands Its Popular Microdialysis Product Line 01-20-12
Bioindustry Support Solutions, LLC Release: STATKING Consulting, Inc. Signs Agreement to Provide Webinar Content 01-20-12
Data on Navidea Biopharmaceuticals??'s AZD4694 Presented by the Banner Alzheimer's Institute at the 6th Annual Human Amyloid Imaging Meeting (HAI) 01-20-12
PolyTherics Acquires and Expands Technology Portfolio to Enable the Development of Better Biopharmaceuticals 01-20-12
Genzyme Corporation and Veracyte, Inc. Announce Global Co-Promotion Agreement to Deliver Personalized Solution for Thyroid Patients 01-20-12
Avila Therapeutics Announces FDA Allowance of PartnerClovis Oncology??'s IND Application for CO-1686, an Oral EGFR Mutant-Selective Inhibitor 01-20-12
Idera Pharmaceuticals, Inc. Announces Favorable Data from Phase 1b Study of IMO-2055 in Combination with Tarceva?? and Avastin?? in Patients with Advanced Non-Small Cell Lung Cancer 01-20-12
Nordion International Enters Six-Year Cobalt-60 Supply Agreement with 01-19-12
ShangPharma Announces Milestone Achievement in Research Partnership with 01-19-12
ShangPharma Achieves First Milestone in Jiangsu Hengrui Medicine Co. Ltd. Biologics Partnership 01-19-12
Watson Pharmaceuticals, Inc. Launches Generic Yaz(R) 01-19-12
Commonwealth Laboratories, Inc. and Health Point Press Announce a New Association Which Will Work to Promote Small Intestinal Bacteria Overgrowth (SIBO) and its Correlation to Irritable Bowel Syndrome (IBS) 01-19-12
A*STAR, GE Global Research Join Forces to Develop Integrated Advanced Medical Imaging Technologies for Improved Clinical Diagnosis 01-19-12
HUYA Bioscience International Announces Strategic Partnership with the 01-19-12
Elsevier, Inc. and Tsinghua University Department of Computer Science and Technology Create New Research Productivity Solutions 01-19-12
Sabin Vaccine Institute Release: Candidate for First Human Hookworm Vaccine Enters Phase 1 Clinical Trial in Brazil 01-19-12
Adeona Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Trimesta(TM) for Cognitive Dysfunction in Multiple Sclerosis 01-19-12
Eisai Company, Ltd. Receives Approval to Market Insomnia Treatment Lunesta in Japan 01-19-12
Ferrer Internacional Initiates Phase III Clinical Studies for Novel Antibacterial Compound, Ozenoxacin, in Development as a Topical Treatment for Impetigo and Other Infectious Dermatological Conditions 01-19-12
Apricus Biosciences Retains as Investor Relations Firm 01-19-12
Complete Genomics, Inc. Publishes Paper Describing Its Informatics Approach for High-Accuracy Whole Human Genome Sequencing 01-19-12
Genta Incorporated Release: New Clinical Trial Confirms the Activity of Tesetaxel in Patients With Advanced Gastric Cancer 01-19-12
Roy D. Baynes, MD, PhD, to Join Gilead Sciences Ltd. as Senior Vice President, Oncology Therapeutics Network 01-19-12
Nancy Hutson Appointed toBiocryst Pharmaceuticals??'s Board of Directors 01-19-12
Precision BioSciences Announces Establishment of for Development of Advanced Agricultural Biotechnology 01-19-12
Biovest International, Inc. Prepares for EU Regulatory Meetings; SME Status Granted Providing European Regulatory Benefits for BiovaxID Personalized Lymphoma Vaccine 01-19-12
Ono Pharmaceutical Company, Ltd. Selects Medidata Rave as Enterprise EDC/CDM Solution 01-19-12
NovaDel Pharma Continuing to Explore Strategic Alternatives 01-19-12
Vitae Pharmaceuticals, Inc. Secures $15 Million Senior Credit Facility 01-19-12
Mayo Clinic Release: New Test Offers Greater Accuracy in Early Detection of Colorectal Cancer 01-19-12
Johannes Gutenberg University Release: First Preclinical Proof-of-Concept of Mutation-Based Individualized Cancer Vaccine 01-18-12
The Medicines Company's Cangrelor Bridge Trial Published in the JAMA 01-18-12
Immunomedics, Inc. Reports Clivatuzumab-Based Blood Test Highly Sensitive and Specific for Early-Stage Pancreatic Cancer Detection 01-18-12
Teijin Pharma's Bonalon Bag for I.V. Infusion 900 ??g Approved as Japan's First I.V. Drug for Osteoporosis 01-18-12
Quintiles, Inc. Takes Stake in UK Biomarker Startup 01-18-12
Courtagen Life Sciences Acquires Medicinal Genomics 01-18-12
inVentiv Health Release: IMS Health Signs Agreement to Divest SDI Medical and Promotional Audits 01-18-12
Rexahn Pharmaceuticals, Inc. Secures Approval in Europe to Conduct a First-in-Human Trial of RX-3117 in Solid Tumors 01-18-12
Gilead Sciences Ltd. Completes Acquisition of Pharmasset, Inc. 01-18-12
Ceptaris Therapeutics, Inc. Receives EMA Orphan Drug Designation for Proprietary Mechlorethamine Gel 01-18-12
Provectus Pharmaceuticals Inc. Receives Guidance From FDA on Pathway to Approval for Phase 3 Trial of PV-10 For Metastatic Melanoma 01-18-12
Mayo Clinic Release: Drug Improves Survival of Colorectal Cancer Patients, Trial Results Show 01-18-12
Jazz Pharmaceuticals, Inc. and Azur Pharma Inc. Combine to Create 01-18-12
Genzyme Corporation Announces European Approval of Framingham Genomic Medicine Inc. Manufacturing Plant 01-18-12
Daiichi Sankyo, Inc. Officials to Monitor New Ranbaxy Laboratories Unit 01-18-12
Xiamen Innovax Biotech Gains Approval for Hepatitis E Vaccine 01-17-12
Protalex, Inc. Announces Completion of Dosing Patients in 4th Cohort of Its Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis 01-17-12
Ventrus Biosciences, Inc. Announces Publication of Prior Phase 2b Study on the Safety and Efficacy of Iferanserin in the Treatment of Hemorrhoid Disease 01-17-12
BrainStorm Cell Therapeutics Inc. Announces Clinical Data Supporting Safety and Efficacy of NurOwn??? Based on Initial Patient Results 01-17-12
Scil Proteins GmbH to Manufacture Reteplase for Actavis 01-17-12
Enzymicals AG and Herbrand PharmaChemicals GmbH Cooperate for Biotechnological Production of Pharmaceuticals and Intermediates 01-17-12
Celldex Therapeutics, Inc. Announces Initiation of Phase 1 Clinical Trial of CDX-301 01-17-12
InVivo Therapeutics Corporation, Geisinger Health System to Conduct Preclinical Study of Injectable Scaffold for Peripheral Nerve Injury for FDA Submission 01-17-12
Da An Gene and Life Technologies Form $5.5 Million JV 01-17-12
Leading Eye Institute to Participate in Advanced Cell Technology??'s Embryonic Stem Cell Clinical Trial for Macular Degeneration 01-17-12
Former Sanofi-Aventis K.K. and US Oncology Executive Joins as Chief Executive Officer 01-17-12
Jiangsu Hengrui Medicine Co. Ltd. and Crown Bioscience, Inc. Announce Antibody Partnership 01-13-12
Swedish Orphan Biovitrum Signs Global Licensing Agreement for Novel Neonatology Treatment from Only for Children Pharmaceuticals 01-13-12
Amerigen Pharmaceuticals Announces Two China-US Deals 01-13-12
Omni Bio Pharmaceutical to Conduct New Human Clinical Trials 01-13-12
First FDA-Approved Study of Stem Cells to Treat Hearing Loss Begins at 01-13-12
Sangart, Inc. Initiates Phase 1b Study of MP4CO in Patients With Sickle Cell Disease 01-13-12
To Bolster Pipeline, GlaxoSmithKline Exec Scouts Prospects 01-13-12
NextDocs Selected by AlwaysOn as a Venture Summit Mid-Atlantic 100 Winner 01-13-12
9th Annual Biotechnology Industry Organization (BIO) Asia International Conference to Feature New Deal Models and Discuss the Future of Innovation in Asia 01-13-12
Genentech Announces First Milestone Payment to Device-Maker ForSight Labs, LLC in Development of Sustained Delivery Lucentis 01-13-12
Amarantus BioSciences, Inc. to be Interviewed on 01-13-12
Agilux Laboratories Announces Validation and Implementation of Thermo Watson Laboratory Information System 01-13-12
Metabolix, Inc. Announces Termination of 01-13-12
Seattle Genetics, Inc. Announces Updates to ADCETRIS??? Prescribing Information 01-13-12
Rainbow BioSciences, LLC Enters New World of Opportunity 01-13-12
Royal DSM is Awarded Membership in the PANOPTES EU Funded Consortium 01-13-12
Nuron Biotech Licenses HibTITER?? Vaccine to Mitsubishi Tanabe Pharma Corporation for Japanese Market 01-13-12
Advanced BioNutrition Corporation and Sign Global Agreement 01-13-12
St. Jude Children's Research Hospital Release: Gene Identified as a New Target for Treatment of Aggressive Childhood Eye Tumor 01-12-12
Three Adimab LLC. Antibodies Enter Human Clinical Trials 01-12-12
Merrimack Pharmaceuticals Inc. Initiates Enrollment in Phase 1 Study of MM-151 in Patients with Refractory Advanced Solid Tumors 01-12-12
Senova Systems, Inc. Inks $6.7 Million Series B 01-12-12
Biovest International, Inc. Collaborates with Max Planck Institute to Advance its Hollow Fiber Bioreactors for the Manufacture of Viral Vaccines 01-12-12
BioReference Laboratories, Inc. Announces Contract with to Provide Correctional Healthcare Laboratory Services 01-12-12
Genethon, Encouraging Results in a Phase I Clinical Trial in Limb-Girdle Muscular Dystrophy Type 2C 01-12-12
Perrigo Company Wins Summary Judgment in Generic Mucinex?? Case 01-12-12
Senova Systems Inks $6.7 Million Series B 01-12-12
PharMerica Drops on Report its Takeover My be Blocked by U.S. Regulators 01-12-12
Pfizer Inc. Contraceptive Seized in India for Misbranding 01-12-12
Cebix Incorporated to Raise $20 Million for Pivotal Trial of Diabetes Supplement 01-11-12
GE Healthcare to Enhance EP Portfolio of Offerings through Biosense Webster, Inc. Agreement 01-11-12
China Nuokang Bio-Pharmaceutical Inc. Broadens Product Portfolio by Acquiring Alpha Lipoic Acid Capsule for Diabetic Patients 01-11-12
Sumagen Initiates Clinical Testing of Omnia Biologics, Inc. Manufactured HIV Vaccine 01-11-12
Pharmos Corporation Announces Dosing of First Patients in Clinical Trial of Levotofisopam for the Treatment of Gout 01-11-12
Vical Incorporated Provides Updates on CMV Vaccine Programs 01-11-12
Gynecologic Oncology Group and Advaxis, Inc. Release: Dosing Begins for GOG US Cervical Cancer Study Evaluating ADXS-HPV 01-11-12
Starpharma Holdings Ltd Receives FDA Special Protocol Assessment for BV Phase 3 01-11-12
FDA Grants Hemispherx Biopharma Extension in Its Pending New Drug Application (NDA) for the Treatment of Chronic Fatigue Syndrome (CFS) 01-11-12
Actelion Ltd. CEO Says Macitentan Has 'Very High' Chances of Success 01-11-12
Polaris Goup Doses First Patient in Phase 1 Clinical Trial of Lead Therapeutic Candidate ADI-PEG 20 in Combination with Docetaxel in Advanced Solid Tumors with Emphasis on Prostate Cancer 01-10-12
Cubist Pharmaceuticals, Inc. and Hydra Biosciences, Inc. Announce Plans to Begin Phase 1 Clinical Trial for Novel TRPA1 Modulator to Treat Acute Pain 01-10-12
Sinovac Biotech Ltd. Commences the Phase III Clinical Trial for its EV71 Vaccine Against Hand, Foot and Mouth Disease 01-10-12
Arena Pharmaceuticals, Inc.: FDA Accepts Resubmission of Lorcaserin New Drug Application 01-10-12
Telormedix Secures Further Funding With $7.5 Million CHF 01-10-12
University of California, San Francisco (UCSF), Sanofi (France) Collaborate to Find New Diabetes Cures 01-10-12
Dako A/S and Amgen to Collaborate in Development of a Companion Diagnostic for an Investigational Cancer Therapy 01-10-12
National Institute for Clinical Excellence (NICE) Seeks More Info on Bayer HealthCare's Xarelto 01-10-12
Genome Institute of Singapore Scientists Identify Lung Cancer Stem Cells and New Drug Targets 01-06-12
Jazz Pharmaceuticals, Inc. Provides Financial Outlook for 2012 01-06-12
Cancer Researcher at Develops Nontoxic Compounds 01-06-12
Goff Hill Ltd. Announces the Cure for Cancer and Viral Diseases 01-06-12
Novel Brain Tumor Vaccine Acts Like Bloodhound to Locate Cancer Cells, Wake Forest University Baptist Medical Center Study 01-06-12
Pharming Group Redeems Part of Convertible Bond 01-06-12
CoDa Therapeutics, Inc., Mesynthes, and Pacific Edge Biotechnology Ltd. (PEB), Release:Showcased to Health Care Investment and Partnering Community 01-06-12
University of California, San Francisco (UCSF) Files Appeal of Judgment in Favor of InSite Vision 01-06-12
ISTA Pharmaceuticals, Inc. Announces U.S. Patent Allowance for PROLENSA(TM) in the United States 01-06-12
KAI Pharmaceuticals, Inc. Announces Initiation of Second Phase 2 Study of KAI-4169 01-06-12
Covidien Completes Acquisition of BARRX Medical, Inc. 01-06-12
Civitas Therapeutics Announces Positive Results from Clinical Study of CVT-301, an Inhaled L-dopa for Parkinson's Disease 01-06-12
Alnylam Pharmaceuticals Files Clinical Trial Application for ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidosis 01-06-12
Amicus Therapeutics, Inc. Announces Positive Preliminary Results From Ongoing Phase 2 Chaperone-Enzyme Replacement Therapy (ERT) Study for Fabry Disease 01-06-12
Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Closes Previously Announced $5 Million Financing 01-06-12
Analysts: Amgen, Celgene Need to Make Acquisitions to Boost Growth 01-06-12
Pharma Firm Norgine Plans 36 Job Losses 01-06-12
DURECT Corporation's Phase III Study Did Not Show Significant Results for Posidur 01-06-12
Pfizer Inc. Restructures Indian Animal-Health Unit to Prepare for Consolidation 01-06-12
Johnson & Johnson to Pay $1 Billion to Settle Risperdal Marketing Probe 01-06-12
Biotech Firm Cangene Corporation Cuts 120 Jobs 01-06-12
Endo Pharmaceuticals to Pay Up to $180 Million Plus Royalties to BioDelivery Sciences International in Drug Pact; Stock Rises +0.97(115.46%) @ 10:12AM EST 01-06-12
Neovacs SA Major Milestone Achieved: The Phase IIa Clinical Trial in Rheumatoid Arthritis Meets Its Endpoint 01-05-12
ThermoGenesis Announces Approval of AXP(R) by 01-05-12
Apogenix Raises ???7.5 Million to Further Advance APG101 to Treat Glioblastoma and Other Tumors 01-05-12
Kraig Biocraft Laboratories, Inc. Announces Peer Reviewed Publication of Spider Silk and Transgenic Silkworm Breakthroughs 01-05-12
Tetragenetics, Inc.??? G-SOME???-Formulated Influenza Vaccine Provides Strong Protection Against H5N1 in Preclinical Efficacy Study 01-05-12
Ritter Pharmaceuticals, Inc.' RP-G28 Improves Lactose Intolerance Symptoms and Lactose Digestion in Phase 2 Trial 01-05-12
ISTA Pharmaceuticals, Inc. Initiates Phase 2 Clinical Study of BEPOSONE(TM) (Bepotastine Besilate - Steroid Combination Nasal Spray) for the Treatment of Symptoms Associated With Seasonal Allergic Rhinitis 01-05-12
Basilea Pharmaceutica to File Application for Marketing Authorization of Ceftobiprole for the Treatment of Pneumonia 01-05-12
Alnylam Pharmaceuticals and Arrowhead Research Corporation Form Collaboration and Licensing Agreement 01-05-12
Senesco Technologies, Inc. and Enter into New Agreement 01-05-12
Ensemble Therapeutics Corporation Extends Macrocycle Drug Discovery Alliance with Bristol-Myers Squibb Company 01-05-12
Vitae Pharmaceuticals, Inc. to Present at the 30th Annual Healthcare Conference 01-05-12
Ironwood Pharmaceuticals and Bionomics Limited Announce Collaboration, Research, and License Agreement 01-05-12
Oncodesign SA and Ipsen Enter into a Research Collaboration for the Development of New Therapeutic Agents against the LRRK2 Parkinson's disease Target 01-05-12
Baxter International, Inc. Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A 01-05-12
ProFibrix US Phase II Study with Meets All Primary and Secondary Endpoints 01-05-12
RegeneRx Biopharmaceuticals, Inc. Receives Clinical Study Report for Phase 2 Dry Eye Trial 01-05-12
Repros Therapeutics Inc. Completes Dosing in Phase 2 Low-Dose Oral Proellex(R) Trial 01-04-12
PolyMedix Inc. Completes Enrollment in Phase 2 Trial With PMX-30063 Defensin-Mimetic Antibiotic 01-04-12
Achillion Pharmaceuticals, Inc. Release: ACH-1625 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C 01-04-12
Veloxis Pharmaceuticals A/S Announces Initiation of STRATO Study of LCP-Tacro(TM) in Kidney Transplant Recipients Experiencing Tremors 01-04-12
Arrowhead Research Corporation Announces FDA Clearance to Initiate AdipotideTM Phase I Clinical Trial 01-04-12
First Human Volunteer Immunized in Clinical Trial of Profectus BioSciences, Inc.??? Vesicular Stomatitis Virus-vectored HIV-1 Vaccine 01-04-12
AVI BioPharma, Inc. Data Safety Monitoring Board Reports No Safety Concerns Identified in Phase IIb DMD Clinical Trial, Recommends Continuation of Trial 01-04-12
Celldex Therapeutics, Inc. Initiates a Phase 2 Study of Rindopepimut in Patients with Recurrent Glioblastoma including Avastin?? Naive and Refractory Populations 01-04-12
Alnylam Pharmaceuticals Reports Positive Preliminary Clinical Results for ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia 01-04-12
Alkermes plc Announces Positive Results From Clinical Study of ALKS 5461 for Major Depressive Disorder 01-04-12
Eppendorf AG Licenses Technology for Thermal Cyclers to 01-03-12
BioMarin Pharmaceutical Inc. Announces IND for BMN-111 for Achondroplasia is Active 01-03-12
Chelsea Therapeutics, Inc. Announces FDA Advisory Committee Meeting Date for Review of NORTHERA(TM) NDA for the Treatment of Symptomatic NOH 01-03-12
FDA's Oncologic Drugs Advisory Committee to Review Cell Therapeutics, Inc.'s Resubmitted Pixantrone New Drug Application on February 9, 2012 01-03-12
XOMA (US) LLC Secures $10 Million Term Loan 01-03-12
Amgen Release: FDA to Review Potential New Use of XGEVA(R) (Denosumab) at Oncologic Drugs Advisory Committee Meeting 01-03-12
Agile Therapeutics, Inc. Announces Completion of AG200-15 Phase III Clinical Program 01-03-12
Osiris Therapeutics, Inc. Provides Update on Groundbreaking Stem Cell Trial for Type 1 Diabetes 01-03-12
XOMA Ltd. Secures $10 Million Term Loan 01-03-12
Astex Pharmaceuticals Announces FDA ODAC Meeting of sNDA Application for Dacogen in Treatment of Elderly AML 01-03-12
Harbin Pharmaceutical Group Holding Co., Ltd. Trades $870 Million of Stock for Assets from Parent 01-03-12
Van Andel Institute Findings Provide More Complete Understanding of Kidney Cancer 12-29-11
Alexion Pharmaceuticals Inc. to Host Conference Call This Morning to Discuss Company??'s Proposed Acquisition of Enobia Pharma 12-29-11
Marshall Edwards, Inc. Adds $2 Million in Private Placement 12-29-11
Opko Health, Inc. Completes Acquisition of FineTech Pharmaceutical, Ltd. 12-29-11
Roche's Avastin Disappoints Against Ovarian Cancer 12-29-11
China Sky One Medical, Inc. Announces Resignation of its Chief Financial Officer 12-29-11
SBS Group Selected as 2011 VAR Star 12-29-11
Biogen, Inc. to Present at the Goldman, Sachs & Co. Healthcare CEOs Unscripted Conference 12-29-11
Peregrine Pharmaceuticals, Inc. Provides Update on HCV Clinical Program 12-29-11
RTI Biologics Achieves 98.7 Percent Equipment Performance Rating ??? Recognized in 12-29-11
Foundation Fighting Blindness Announces $1.8 Million Grant to Leading Netherlands Institute, Expands International Research Portfolio 12-29-11
Alexion Pharmaceuticals Inc. to Host Conference Call This Morning to Discuss Company??'s Proposed Acquisition of Enobia Pharma 12-29-11
AAIPharma Services Achieves Record Quarterly Results 12-29-11
IGI Laboratories, Inc. Announces the Submission of Fifth ANDA 12-29-11
Opko Health, Inc. Completes Acquisition of 12-29-11
FDA Accepts New Drug Application for Gilead Sciences, Inc.??'s Once-Daily, Single-Tablet Quad HIV Regimen 12-28-11
United Therapeutics Corporation Release: Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union 12-28-11
IntelGenx Corp. Announces Health Canada Approval for Anti-Migraine VersaFilm Pivotal Clinical Trial 12-28-11
ThromboGenics NV Submits Biologics License Application for Ocriplasmin to the U.S. FDA 12-28-11
VIVUS, Inc. Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity 12-28-11
Protox Therapeutics Inc. Announces Closing of Additional CDN $8.3 Million Investment by Warburg, Pincus Ventures, L.P. 12-28-11
Beijing Double-Crane Pharmaceutical Co., Ltd. Buys Transfusion Maker for $17.4 Million 12-28-11
Albany Molecular Research, Inc. (AMRI) Cuts Jobs in Q4 12-28-11
22nd Century Group, Inc. Announces Initial Results of Smoking Cessation Trial 12-28-11
Emergent BioSolutions Initiates Phase 2 Study of TRU-016 in Combination with Bendamustine in Patients with Relapsed Chronic Lymphocytic Leukemia 12-28-11
Bristol-Myers Squibb Company Release: BRISK-PS Study with Investigational Compound Brivanib in Hepatocellular Carcinoma Completed 12-28-11
EpiCept Corporation Receives FDA Permission to Initiate AmiKet??? Phase III Clinical Development 12-28-11
Noven Pharmaceuticals Inc. Announces Phase 3 Results for Investigational Non-Hormonal Therapy for Vasomotor Symptoms 12-28-11
CEL-SCI Announces Fiscal 2011 Financial Results 12-28-11
Anacor Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase 3 Trials of Tavaborole for Onychomycosis 12-28-11
FDA Accepts New Drug Application for Gilead Sciences Ltd.??'s Once-Daily, Single-Tablet Quad HIV Regimen 12-28-11
Perrigo Company Announces FDA Final Approval for Desloratadine 12-28-11
Fero Industries, Inc. Signs New Distribution Agreement to Expand Sucanon(R) Presence in the Middle East 12-22-11
New CEO Appointed Head of 12-22-11
Ventrus Biosciences, Inc. Completes Enrollment of Pivotal Phase 3 Trial of Diltiazem (VEN 307) in Patients With Anal Fissures 12-22-11
Eisai Company, Ltd. Submits Application for Partial Change to Label of Egg White Lysozyme Preparation Neuzym 12-22-11
Tekmira Pharmaceuticals Corporation Secures $3 Million Financing 12-22-11
CytRx Corporation Initiates International Phase 2b Clinical Trial with INNO-206 in Advanced Soft Tissue Sarcoma 12-22-11
AVEO Pharmaceuticals, Inc. Announces Patient Enrollment in Phase 2 Clinical Trial of Tivozanib in Combination with mFOLFOX6 in Patients with Advanced Colorectal Cancer 12-22-11
Curis, Inc. Announces Collaborator Roche??'s Submission of Marketing Authorization Application for Vismodegib in Advanced Basal Cell Carcinoma 12-22-11
IMPAX Laboratories, Inc. Asks FDA for Approval of Parkinson's Drug 12-22-11
New C.E.O. Appointed Head of 12-22-11
Chelsea Therapeutics, Inc. Reports Topline Results From Phase II Trial of Droxidopa in Fibromyalgia 12-22-11
Pfizer Inc. Reports Results From Three Phase 4 Studies Demonstrating EMBEDA?? (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact on Drug Liking and Withdrawal Symptoms 12-22-11
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson??'s Disease 12-21-11
Raptor Pharmaceutical Inc. Provides Program Update on RP103 (DR Cysteamine) for Nephropathic Cystinosis 12-21-11
OphthaliX Inc. Release: Denali Concrete Management Inc. Announces the Commencement of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study 12-21-11
Santarus Inc. Submits New Drug Application to FDA for UCERIS (budesonide) Tablets 12-21-11
BioTie Therapies Corp.'s Partner Lundbeck Inc. Submits European Marketing Authorization Application for Selincro(TM) (nalmefene) 12-21-11
Salix Pharmaceuticals, Ltd. Completes Acquisition of Oceana Therapeutics 12-21-11
Celldex Therapeutics, Inc. Completes Accrual of CDX-011 Phase 2b ???EMERGE??? Study in Advanced Breast Cancer 12-21-11
Santarus Inc. Submits New Drug Application to FDA for UCERIS (budesonide) Tablets 12-21-11
Repligen Corporation Announces Submission of New Drug Application for SecreFlo??? for Improved Pancreatic Imaging In Patients with Pancreatitis 12-21-11
Gilead Sciences, Inc. Files European Marketing Application for the Quad, a Once-Daily Single-Tablet Regimen for the Treatment of HIV Infection 12-21-11
Phage Pharmaceuticals (Formerly Known as Phage Biotechnology Corp.) to File Investigational New Drug (IND) Application Using Its Lead Drug Candidate, FGF-1, for a First-in-Class Indication to Repair Tympanic Membrane Perforations 12-21-11
Zogenix, Inc. Completes Zohydro(TM) Pre-NDA Meetings With FDA 12-20-11
Zogenix, Inc. and Astellas Pharma US Agree to End Co-Promotion for SUMAVEL(R) DosePro(R) Effective March 31, 2012 12-21-11
Record Breaking $327 Million Verdict Upheld in Janssen Pharmaceutical K.K. Case and Request for New Trial Denied 12-21-11
Antares Pharma, Inc. Enters Licensing Agreement with Pfizer Consumer Healthcare 12-20-11
MacroGenics, Inc. Receives Milestone Payment as Part of Its Global DART??? Alliance With Boehringer Ingelheim Corporation 12-20-11
Hua Medicine Licenses Novel Drug Candidate From Roche for Potential Treatment of Diabetes 12-20-11
Orexo AB: Positive Study Results for OX27 12-20-11
Provectus Pharmaceuticals Inc. and its Subsidiaries Complete Unregistered Offering of Units to Facilitate Spin-off of 12-20-11
DARA BioSciences, Inc. Reports Appointment of as a Director and Designation of as President and Chief Executive Officer 12-20-11
ProteoTech Announces Drug Development Collaborative Agreement with GlaxoSmithKline for New Parkinson's Therapeutic 12-20-11
China Sky One Medical, Inc.'s Chief Executive Officer to Take Sick Leave 12-20-11
Clinuvel Announces Positive Results From Pivotal European Phase III Study: Endpoints Demonstrate Clinically Relevant Treatment Effect of Afamelanotide 12-19-11
Raptor Pharmaceutical Inc. Signs Collaborative Research and Development Agreement With NIDDK on Phase 2b Clinical Trial of RP104 (DR Cysteamine Tablets) in Non-Alcoholic Steatohepatitis ("NASH") 12-19-11
Pacira Pharmaceuticals, Inc. Announces Results from EXPAREL(TM) Pivotal Trial Published in Diseases of the Colon & Rectum 12-19-11
Amicus Therapeutics, Inc. Completes Enrollment of 67 Patients in Phase 3 Study of Migalastat HCl for Fabry Disease 12-19-11
Planning for Patrys Limited' Multiple Myeloma Trial Underway 12-19-11
Ardea Biosciences, Inc. Initiates Phase 3 Clinical Development Program for Lesinurad 12-19-11
Zalicus Inc. Initiates Phase 1 Clinical Trial of Z944 12-19-11
Alkermes plc Initiates Phase 3 Clinical Study of ALKS 9070 for Treatment of Schizophrenia 12-19-11
AbGenomics Corporation Regains Global Rights to AbGn-168H from Boehringer Ingelheim Corporation 12-19-11
AmerisourceBergen Corporation Release: US Bioservices Corporation Receives Accreditation 12-19-11
Kinex Pharmaceuticals Acquires Rights for Technology and Products from Hanmi Pharmaceutical, Co., Ltd, in United States and European Union Territories 12-19-11
Galapagos NV Achieves Clinical Proof-of-Mechanism Milestone in GlaxoSmithKline Alliance 12-19-11
VHGI Holdings, Inc. Announces Intent to Spin-Out Medical Office Software Subsidiary 12-19-11
AstraZeneca PLC's Brilique is First Drug to Gain Post-AMNOG Decision in Germany 12-19-11
Alexza Pharmaceuticals, Inc. Explores Sale, Warns of Job Cuts 12-19-11
ChromaDex, Inc. Announces Successful Completion of Patient Enrollment for the First Human Clinical Study of its Proprietary pTeroPure(R) 12-16-11
NeurogesX, Inc. Confirms FDA Advisory Committee to Review sNDA for Qutenza(R) (capsaicin) 8% Patch for HIV-Associated Peripheral Neuropathy (HIV-PN) 12-16-11
Valeant Pharmaceuticals International Launches $327 Million Hostile Bid for ISTA Pharmaceuticals, Inc., Rejects Offer 12-16-11
AHF Slams Gilead Sciences Ltd. ???HIV Prevention Pill??? FDA Application 12-16-11
Company Profile for 12-16-11
Landmark Publication Endorses PRANA Biotechnology's Drug Pipeline Strategy for Treating Neurodegenerative Diseases 12-16-11
BioTime??'s Subsidiary OncoCyte Corporation Announces Plans for the Novel Pan-Cancer Diagnostic Product PanC-DxTM 12-16-11
Seventh Sense Biosystems Inc. Receives $3.28 Million Grand Challenges Grant to Expand Touch Activated Phlebotomy??? Technology Platform 12-16-11
Laboratory Corporation of America Holdings (LabCorp) Successfully Completes Acquisition of Orchid Cellmark 12-16-11
Omnicare, Inc. Files Amendment to Tender Offer to Acquire PharMerica 12-16-11
Galectin Therapeutics Presents Preclinical Data on the Treatment of Fatty Liver Disease and Fibrosis at 12-16-11
FDA Approves Baxter International, Inc.??'s ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children with Hemophilia A 12-16-11
ThromboGenics Ltd. and BioInvent Complete Enrolment of Phase IIb Trial with TB-402 Ahead of Schedule 12-16-11
Advaxis, Inc. Reports Preliminary Data from ADXS-HPV Phase 2 Trial in Patients with Recurrent/Refractory Cervical Cancer at 12-16-11
Radius Takes Final Bite of its $91 Million Financing Apple 12-16-11
#1 Branded Topical Acne Product, Epiduo(R) Gel of Galderma Laboratories, Receives FDA Approval for a New Convenient Pump Dispenser Third Rock Ventures 12-15-11
Isis Pharmaceuticals, Inc. Updates KYNAMRO Submission Timeline 12-15-11
Vertex Pharmaceuticals Incorporated Release: FDA Grants Priority Review for KALYDECO??? (ivacaftor), the First Potential Medicine to Target the Underlying Cause of Cystic Fibrosis 12-15-11
Repros Therapeutics Inc. Meets With the Divisions of Urologic and Endocrinologic Products at FDA to Plan Direction of Phase 3 Program for Androxal(R) 12-15-11
#1 Branded Topical Acne Product, Epiduo(R) Gel of Galderma Laboratories, Receives FDA Approval for a New Convenient Pump Dispenser 12-15-11
Emisphere Technologies, Inc. Reports Update on the Clinical Development of Oral Calcitonin in Osteoarthritis and Osteoporosis 12-15-11
Eisai Company, Ltd. Announces Canadian Approval of its Anticancer Agent Halaven 12-15-11
ViroPharma Incorporated Announces Approval of Modernized Labeling for Vancocin(R) (Vancomycin Hydrochloride, USP) Capsules 12-15-11
PRANA Biotechnology Commences Alzheimer's Trial Recruitment 12-15-11
REGENX BioSciences Highlights Gene Therapy Advances in the Prevention and Treatment of HIV and Hemophilia B Using NAV(TM) rAAV8 Vectors 12-15-11
FDA Will Not Require a Risk Evaluation and Mitigation Strategy in Connection With Corcept Therapeutics Inc.'s Proposed Distribution of Korlym(TM) for Cushing's Syndrome 12-15-11
AvidBiotics Release: DGR Technology Platform for Engineering Proteins Advanced in Publication by Collaborators 12-15-11
Sartorius AG Closes Acquisition of the Biohit Liquid Handling Business 12-15-11
Cancer Prevention Coalition: Multiple Carcinogens in Johnson & Johnson??'s Baby Shampoo 12-15-11
NuGEN Technologies, Inc. Sample Preparation Solutions Selected by Rutgers University Cell and DNA Repository for Large Scale Alcoholism Study 12-15-11
Human Genome Sciences, Inc. and GlaxoSmithKline Initiate Phase 3 Trial of Belimumab (BENLYSTA??) Administered Subcutaneously in Subjects with Systemic Lupus Erythematosus 12-15-11
BioSante Pharmaceuticals, Inc. Announces Results from LibiGel?? Efficacy Trials 12-15-11
Rib-X Pharmaceuticals, Inc. Reports Positive Top-Line Data from Phase 2b Study of Delafloxacin in Patients with Acute Bacterial Skin and Skin Structure Infections 12-15-11
FDA Grants Priority Review for KALYDECO??? (ivacaftor), the First Potential Medicine to Target the Underlying Cause of Cystic Fibrosis 12-15-11
Meta-analysis of Five Clinical Trials Including Columbia Laboratories, Inc.??? PREGNANT Study Published in 12-14-11
Salix Pharmaceuticals, Ltd. Announces NDA Submission for Crofelemer for the Treatment of HIV-Associated Diarrhea 12-14-11
Merrimack Pharmaceuticals Inc. Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers 12-14-11
Pharmacyclics, Inc. Announces Updated Results for BTK Inhibitor PCI-32765 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma at American Society of Hematology (ASH) Annual Meeting 12-14-11
Celgene International S??rl Release: Phase III Study Evaluating REVLIMID?? in Patients with High-Risk Smoldering Multiple Myeloma Presented at 12-14-11
Quintiles, Inc. Launches China CRO, 12-14-11
Johnson & Johnson Appoints New Chief of Marketing, PR After Recalls 12-14-11
Linguamatics Ltd and ChemAxon Ltd. Announce Project to Enhance Text Mining in Chemistry 12-14-11
NeurOp Corporation Announces Extension to Drug Discovery Collaboration with Bristol-Myers Squibb Company 12-14-11
Mayo Clinic Release: Scientists Develop Vaccine That Successfully Attacks Breast Cancer in Mice 12-14-11
Celgene International S??rl Release: in Adult Lymphoma Research (GELA) Chooses REVLIMID?? for Study in Second Most Common Lymphoma Subtype 12-14-11
Idera Pharmaceuticals, Inc. Presents Data in Preclinical Models of Lymphoma on IMO-4200, a Dual Agonist of TLRs 7 and 8, at the American Society of Hematology 12-14-11
Celgene International S??rl Release: Final Phase II Data Evaluating REVLIMID?? and Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia 12-14-11
Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate?? (Romiplostim) 12-14-11
Threshold Pharmaceuticals, Inc. Announces Promising Phase 1 Clinical Trial Results in Patients With Advanced Leukemias 12-14-11
Celgene International S??rl Release: Phase III Study Evaluating REVLIMID?? in Patients with High-Risk Smoldering Multiple Myeloma Presented at Celgene International S??rl 12-14-11
Salix Pharmaceuticals, Ltd. Announces NDA Submission for Crofelemer for the Treatment of HIV-Associated Diarrhea 12-14-11
The Best Biotech CEO of 2011 Is... 12-14-11
Celgene International S??rl Release: Phase III Study with REVLIMID?? Continuous Therapy Demonstrates Statistically Significant Improvement in Progression-Free Survival for Patients Newly Diagnosed with Multiple Myeloma 12-13-11
PCI Synthesis Completes R&D Expansion of 30%, Adds 20 New Hires & Signs Agreement With Biogen Idec, Inc. (Massachusetts) 12-13-11
Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA(TM) Oral Calcitonin 12-13-11
Eisai Company, Ltd. Submits Application in Japan for New Dry Syrup Formulation of its Alzheimer's Disease Treatment Aricept 12-13-11
Lannett Company, Inc. Receives FDA Approval for Triamterene with Hydrochlorothiazide 37.5/25mg Capsules 12-13-11
GenVec Inc. President and Chief Executive Officer Announces Retirement 12-13-11
Catabasis Pharmaceuticals, Inc. Raises VC for Hypertriglyceridemia Treatment 12-13-11
Daiichi Sankyo, Inc. Release: Edoxaban Significantly Reduces Risk of Venous Thromboembolism by Half Compared to Enoxaparin in Japanese and Taiwanese Patients Following Knee or Hip Arthroplasty Surgery 12-13-11
Celgene International S??rl Release: Final Data from Phase II Multi-Center Study Evaluating Combination of VIDAZA?? and REVLIMID?? in Higher-Risk MDS Patients Presented at American Society of Hematology 12-13-11
Cubist Pharmaceuticals, Inc. Announces First Patient Dosed in Pivotal Global Phase 3 Trial of CXA-201 for Complicated Intra-Abdominal Infections 12-13-11
Celgene International S??rl Release: Phase II Study of ISTODAX?? in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL): A Sub-Analysis of Patients with Most Common Subtypes of PTCL Presented at American Society of Hematology 12-13-11
Lannett Company, Inc. Receives FDA Approval for Triamterene with Hydrochlorothiazide 37.5/25mg Capsules 12-13-11
Celgene International S??rl Release: Phase III Study with REVLIMID?? Continuous Therapy Demonstrates Statistically Significant Improvement in Progression-Free Survival for Patients Newly Diagnosed with Multiple Myeloma 12-13-11
Top-Line Phase 2 Data Indicate Repros Therapeutics Inc.'s Androxal(R) Normalizes Testicular Function in Men With Type 2 Diabetes 12-13-11
Two Novartis AG Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna?? Compared to Gleevec?? 12-13-11
Symphogen A/S Presents Positive Rozrolimupab (SYM001) Phase 2 Trial Results in ITP at American Society of Hematology 12-13-11
Cell Therapeutics, Inc. and Chroma Therapeutics Final OPAL Phase II Results of Tosedostat Demonstrate Significant Response Rates in Elderly Patients with Treatment Refractory or Relapsed Primary or Secondary Acute Myeloid Leukemia (AML) 12-13-11
Onconova Therapeutics Inc. to Present Data Demonstrating Survival Benefit in MDS Patients Treated with Rigosertib and Phase I Data for Oral Rigosertib at the American Society of Hematology Annual Meeting 12-12-11
Optimer Pharmaceuticals, Inc. Release: The European Commission (EC) Grants Marketing Authorization for DIFICLIR(TM) (fidaxomicin) Tablets for Treatment of Clostridium difficile Infections 12-12-11
Nektar Therapeutics (CA) Initiates Phase 3 BEACON Trial of NKTR-102 in Women with Metastatic Breast Cancer 12-12-11
American Society of Hematology to Present Data Demonstrating Survival Benefit in MDS Patients Treated with Rigosertib and Phase I Data for Oral Rigosertib at the American Society of Hematology Annual Meeting 12-12-11
Celladon Corporation Receives FDA Fast Track Designation for Its Investigational Agent MYDICAR?? for the Treatment of Heart Failure 12-12-11
Soligenix Announces Publication of Results of its Phase 2 Clinical Trial of orBec?? in the Prevention of Acute GVHD 12-12-11
Rockwell Medical Technologies Data Safety Monitoring Board Recommends Phase III CRUISE Studies Continue as Planned 12-12-11
Sunesis Pharmaceuticals, Inc. Announces Participation in Cardiff University Sponsored Phase 2/3 Trial Evaluating Vosaroxin in Newly Diagnosed Elderly AML and High-Risk MDS Patients 12-12-11
Micromet??'s Blinatumomab Produces Durable Responses in Patients with Relapsed Diffuse Large B Cell Lymphoma Patients 12-12-11
Celator?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the tor?? Pharmaceuticals and the Leukemia & Lymphoma Society??12-12-11
CytRx Corporation Announces the Presentation of Favorable Phase 2 Clinical Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia at American Society of Hematology Conference 12-12-11
Theravance, Inc. Announces Initiation of Phase 2 Study With Its MARIN Compound, TD-9855, for the Treatment of ADHD 12-12-11
Geron Corporation Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer 12-12-11
Array BioPharma, Inc. Release: ARRY-520 Demonstrates Durable Single-Agent Activity in Patients with Advanced Multiple Myeloma 12-12-11
University College Dublin and Elan Corporation PLC Announce Initiative to Create Leadership in Biotechnology 12-12-11
Breckenridge Pharmaceutical, Inc. Announces Approval of Methscopolamine Bromide Tablets 12-12-11
Vertex Pharmaceuticals (MA) and Alios BioPharma Begin Clinical Studies of Nucleotide Drug Candidates ALS-2200 and ALS-2158 for the Treatment of Hepatitis C 12-09-11
Furiex Pharmaceuticals, Inc. Announces Results for Phase II Trial of PPD-10558 12-09-11
Gilead Sciences, Inc. Announces Two-Year Data From Pivotal Phase 3 Study of Elvitegravir, an Integrase Inhibitor for HIV 12-09-11
Boehringer Mannheim Corporation Completes Patient Entry for Phase III Trial Program in Hepatitis C 12-09-11
Beijing SL Pharma Buys Stake in Forwell Biopharm for $14 Million 12-09-11
Galena Biopharma Presents Phase 2 Trial Design for NeuVax(TM) (E75 + GM-CSF) Combined With Herceptin(R) (Trastuzumab) at the 34th Annual 12-09-11
Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals, Inc.' VALOR Trial Based on Periodic Safety Review 12-09-11
Generex Biotechnology Corporation Release: Breast Cancer Vaccine Reduces Cancer Recurrence in Women: Interim Results From Phase 2 Clinical Trial Trend Toward AE37 Vaccine Benefit; Results Presented at 12-09-11
Enzon Pharmaceuticals, Inc. Presents Data From Phase II PEG-SN38 (EZN-2208) Study in Patients With Metastatic Breast Cancer 12-09-11
U.S. Federal Trade Commission Approves LabCorp??'s Acquisition of Orchid Cellmark 12-09-11
Moberg Derma and Menarini Group Sign Agreement for Emtrix in Italy 12-09-11
Merck & Co. (Westpoint, PA) in New Agreement with Merck & Co., Inc. to Advance Glycan Biomarker Discovery in Diabetes 12-09-11
Vertex Pharmaceuticals Incorporated and Alios BioPharma Begin Clinical Studies of Nucleotide Drug Candidates ALS-2200 and ALS-2158 for the Treatment of Hepatitis C 12-09-11
AEterna Zentaris Presents Positive Preclinical Data in Breast Cancer on AEZS-131, a Highly Selective Erk 1/2 Inhibitor, at 12-09-11
Boehringer Ingelheim Corporation Completes Patient Entry for Phase III Ttrial Programme in Hepatitis C 12-09-11
Furiex Pharmaceuticals, Inc. Announces Results for Phase II Trial of PPD-10558 12-09-11
NanoString Technologies Inc. Announces Positive Results From First Validation Study of PAM50-based Breast Cancer Assay 12-09-11